Panel Discussion: Bridging Regional & Global Priorities to Inform the Selection of CDx Partners & Workflows

• Exploring how Japan-specific regulatory, clinical, and reimbursement considerations can be aligned with global CDx development strategies
• Sharing practical approaches for selecting CDx partners and designing workflows that balance regional requirements with global launch objectives

Speakers:

Takaaki Miyazaki

Biomarker Expert

Bayer

Zach Boyd

Vice President - Global Head of Precision Medicine & Diagnostics

Johnson & Johnson

Brian Jin

BD CDx Operation & US Lab Head

Amoy Diagnostics

Harvey Dong

Vice President, Head of Global CDx Business Development

Amoy Diagnostics

Sophie cui

Director, Biomarker IVD

Gilead Sciences